Mymetics Corporation Share Price Other OTC
Equities
MYMX
US62856A1025
Biotechnology & Medical Research
Sales 2021 | 430K 467K 36.73M | Sales 2022 | 1.03M 1.12M 87.81M | Capitalization | 8.51M 9.25M 727M |
---|---|---|---|---|---|
Net income 2021 | -4M -4.34M -342M | Net income 2022 | -4M -4.34M -342M | EV / Sales 2021 | 177 x |
Net Debt 2021 | 67.1M 72.86M 5.73B | Net Debt 2022 | 71.68M 77.84M 6.12B | EV / Sales 2022 | 78 x |
P/E ratio 2021 |
-1.86
x | P/E ratio 2022 |
-1.77
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 48.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 30/06/09 | |
Mario Amacker
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Staehelin
BRD | Director/Board Member | 76 | 01/07/07 |
Ulrich Burkhard
BRD | Director/Board Member | 63 | 22/03/12 |
Marcel B. Rüegg
BRD | Director/Board Member | - | 15/01/23 |
1st Jan change | Capi. | |
---|---|---|
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |